Published in Nature on August 17, 1989
Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med (1997) 2.94
Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes. Immunity (2015) 1.91
T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med (1990) 1.79
A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med (1997) 1.67
In vivo and in vitro clonal deletion of double-positive thymocytes. J Exp Med (1992) 1.66
Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med (1996) 1.49
A special repertoire of alpha:beta T cells in neonatal mice. EMBO J (1991) 1.47
Failure of clonal deletion in neonatally thymectomized mice: tolerance is preserved through clonal anergy. J Exp Med (1990) 1.42
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci U S A (1996) 1.31
Rapid deletion of rearranged T cell antigen receptor (TCR) Valpha-Jalpha segment by secondary rearrangement in the thymus: role of continuous rearrangement of TCR alpha chain gene and positive selection in the T cell repertoire formation. Proc Natl Acad Sci U S A (1998) 1.26
Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k). J Immunol (2011) 1.15
Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice. Proc Natl Acad Sci U S A (1990) 1.14
CD8 is required during positive selection of CD4-/CD8+ T cells. J Exp Med (1990) 1.11
Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med (1997) 1.04
A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction. J Exp Med (1999) 1.00
The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med (1999) 0.98
Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide. J Exp Med (1992) 0.97
Negative selection of thymocytes expressing the D10 TCR. Proc Natl Acad Sci U S A (2002) 0.92
Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J Clin Invest (2011) 0.86
Prss16 is not required for T-cell development. Mol Cell Biol (2005) 0.84
Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis (1993) 0.83
A novel immunosuppressant, FTY720, increases the efficiency of a superantigen-induced peripheral T-cell deletion whilst inhibiting negative selection in the thymus. Immunology (1998) 0.81
The stage of negative selection in tolerance induction in neonatal mice. Immunology (1991) 0.80
Orally tolerant CD4 T cells respond poorly to antigenic stimulation but strongly to direct stimulation of intracellular signaling pathways. Cytotechnology (2001) 0.75
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (1989) 9.01
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature (1984) 8.89
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell (1989) 7.02
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (1984) 6.08
Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol (1991) 5.71
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell (1994) 4.60
The immunological synapse. Annu Rev Immunol (2001) 4.45
Somatic recombination in a murine T-cell receptor gene. Nature (1984) 4.21
Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature (1984) 4.15
Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (1992) 4.01
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science (1998) 3.76
DNA sequences mediating class switching in alpha-immunoglobulins. Science (1980) 3.70
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Cell-type-specific cDNA probes and the murine I region: the localization and orientation of Ad alpha. Proc Natl Acad Sci U S A (1984) 3.43
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature (1988) 3.43
Antigen-specific development of primary and memory T cells in vivo. Science (1995) 3.41
Structural gene sets active in embryos and adult tissues of the sea urchin. Cell (1976) 3.38
CDR3 length in antigen-specific immune receptors. J Exp Med (1994) 3.35
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol (1999) 3.33
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
Differential clustering of CD4 and CD3zeta during T cell recognition. Science (2000) 3.30
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell (1989) 3.29
A third type of murine T-cell receptor gene. Nature (1984) 3.24
A human T cell-specific molecule is a member of a new gene family. J Immunol (1988) 3.21
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A (1979) 3.19
A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature (1987) 3.08
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
T-cell receptor delta gene rearrangements in early thymocytes. Nature (1988) 2.88
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med (2000) 2.78
Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature (1984) 2.71
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci U S A (1998) 2.69
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol (1997) 2.53
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity (1998) 2.52
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 2.17
Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol (1994) 2.15
Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) (2009) 2.09
Identification of self through two-dimensional chemistry and synapses. Annu Rev Cell Dev Biol (2001) 1.99
Molecular components of T-cell recognition. Annu Rev Immunol (1992) 1.96
Localization of a T-cell receptor diversity-region element. Nature (1984) 1.96
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Regulating the retention of T-cell receptor alpha chain variants within the endoplasmic reticulum: Ca(2+)-dependent association with BiP. J Cell Biol (1991) 1.93
Not without my permission: parents' willingness to permit use of newborn screening samples for research. Public Health Genomics (2009) 1.92
Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med (1991) 1.92
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. Immunity (2000) 1.83
Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81
Molecular genetics of the T cell-receptor beta chain. Annu Rev Immunol (1985) 1.76
Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity (1998) 1.74
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci U S A (1993) 1.71
Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med (1985) 1.65
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Experience with juvenile polyps in North American children: the need for pancolonoscopy. Am J Gastroenterol (2001) 1.61
Ligand-specific oligomerization of T-cell receptor molecules. Nature (1997) 1.58
The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell (1990) 1.58
Formation of a highly peptide-receptive state of class II MHC. Immunity (1998) 1.58
Expression of genes of the T-cell antigen receptor complex in precursor thymocytes. Nature (1985) 1.57
A murine T cell receptor gene complex: isolation, structure and rearrangement. Immunol Rev (1984) 1.56
T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med (1990) 1.55
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity (1997) 1.55
Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med (1997) 1.51
GROUP MEDICINE. Am J Public Health (N Y) (1919) 1.50
Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning. Proc Natl Acad Sci U S A (1999) 1.47
Immunoglobulin class switching: developmentally regulated DNA rearrangements during differentiation. Cell (1980) 1.46
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia. Cancer Res (1999) 1.45
Helper and killer T cells do not express B cell immunoglobulin joining and constant region gene segments. J Exp Med (1980) 1.42
C. M. A. DEPARTMENT OF PUBLIC RELATIONS: DO CORPORATIONS PRACTICE MEDICINE? Cal West Med (1932) 1.41
Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc Natl Acad Sci U S A (2001) 1.38
Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment. Blood (2001) 1.37
pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J (1992) 1.36
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond. Cancer Immunol Immunother (2010) 1.36
Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones. Proc Natl Acad Sci U S A (1986) 1.35
A kinetic window constricts the T cell receptor repertoire in the thymus. Immunity (2001) 1.32
Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies. J Immunol (2000) 1.32
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J Exp Med (1993) 1.31
Activation and differentiation requirements of primary T cells in vitro. Proc Natl Acad Sci U S A (1993) 1.29
Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med (1999) 1.28
The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc Natl Acad Sci U S A (2000) 1.24
Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J Immunol (1993) 1.24